Skip to the page

Data / Form D filings / Nascent Pharma Holdings, Inc.

Nascent Pharma Holdings, Inc.: Form D filing

Nascent Pharma Holdings, Inc., a company in Hicksville, NY, filed a Form D with the SEC in 2026. The latest, on April 10, 2026, reports $75,000 sold of a $3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
44 East End Avenue, Hicksville, NY, 11801
Phone
(516) 595-9544
Industry
Other
Entity type
Corporation
Incorporated in
Florida
Year incorporated
2024
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2042814

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 10, 2026New notice$3,000,000$75,000$2,925,0002Mar 12, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Marco AlfonsiExecutive Officer, Director
Stanley TeepleExecutive Officer, Director
Frederick Alger BoyerDirector

Other companies in New York that filed recently

Every Form D from the week of Apr 6, 2026 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Nascent Pharma Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.